---
schema_version: "secwatch.filing_event.v1"
accession: "0001321732-21-000059"
form_type: "8-K"
ticker: "PEN"
cik: "0001321732"
company_name: "Penumbra Inc"
filed_at: "2021-08-09T23:59:59+00:00"
generated_at: "2026-06-29T18:10:57.806727+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Penumbra Q2 revenue $184.3M (+75.3% YoY); raises FY2021 guidance to $720-730M

## Summary
- Revenue $184.3M (+75.3% YoY); vascular $100.7M (+117.6%), neuro $83.6M (+42.0%).
- Operating income of $10.3M vs. operating loss of $17.6M in Q2 2020.
- Gross margin improved to 64.4% from 61.8%.
- Full-year 2021 revenue guidance raised to $720-730M from $695-705M (28-30% growth).
- No EPS figure provided in release.

## SEC filing metadata
- accession: 0001321732-21-000059
- form_type: 8-K
- ticker: PEN
- cik: 0001321732
- company_name: Penumbra Inc
- filed_at: 2021-08-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1321732/000132173221000059/0001321732-21-000059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1321732/000132173221000059/pen-20210809.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001321732-21-000059
- JSON: https://secwatch.observer/filing/0001321732-21-000059.json
- Plain text: https://secwatch.observer/filing/0001321732-21-000059.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.